tiprankstipranks
Renalytix (RNLXY)
OTHER OTC:RNLXY
US Market

Renalytix (RNLXY) Financial Statements

Compare
234 Followers

Renalytix Financial Overview

Renalytix's market cap is currently $48.11M. The company's EPS TTM is $-0.514; its P/E ratio is ―; Renalytix is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Jun 23Jun 22Jun 21Jun 20
Income Statement
Total Revenue
Gross Profit$ 156.00K$ 720.00K$ 874.00K$ 687.00K-
Operating Income$ -29.61M$ -42.22M$ -53.30M$ -25.43M$ -10.31M
EBITDA$ -33.09M$ -45.10M$ -52.69M$ -33.69M$ -9.77M
Net Income$ -33.46M$ -45.61M$ -41.44M$ -31.01M$ -9.84M
Balance Sheet
Cash & Short-Term Investments$ ―$ ―$ ―$ ―$ ―
Total Assets$ 7.97M$ 30.63M$ 50.06M$ 78.58M$ 20.92M
Total Debt$ 8.54M$ 12.12M$ 12.34M$ 0.00$ 255.00K
Net Debt$ 3.85M$ -12.56M$ -28.99M$ -65.13M$ -14.02M
Total Liabilities$ 15.83M$ 23.66M$ 19.46M$ 7.12M$ 4.97M
Stockholders' Equity$ ―$ ―$ ―$ ―$ ―
Cash Flow
Free Cash Flow$ -30.11M$ -34.09M$ -46.59M$ -29.17M$ -10.33M
Operating Cash Flow$ -30.11M$ -34.09M$ -45.92M$ -28.40M$ -9.52M
Investing Cash Flow
Financing Cash Flow
Currency in USD

Renalytix Earnings and Revenue History

Renalytix Debt to Assets

Renalytix Cash Flow

Renalytix Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis